Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page
- Check5 days agoChange DetectedThe study page version was updated from v3.6.2 to v3.6.3, signaling a minor revision to the record metadata.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision metadata has been updated from v3.6.0 to v3.6.2, indicating a newer version of the study details page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now shows 'No longer looking for participants', signaling that recruitment has closed. It indicates the study is not accepting new participants.SummaryDifference0.4%

- Check34 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new software build. This change does not modify study information or user-facing features beyond the version badge.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page has been updated to revision v3.5.3, replacing v3.5.2, indicating a minor maintenance release for the page. This change does not alter the study content or key information presented on the page.SummaryDifference0.1%

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.